ImmunoGen, Inc. provided earnings guidance for the year 2022. For the year, the company now expects revenues between $80 million and $90 million.
1st Jan change | Capi. | |
---|---|---|
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |